 My name is Andrew Ip. I'm a director of our Outcomes and Value Care Division and also a member of our lymphoma division. So really we're in the new age of immunotherapy and treating lymphoma at this time and what that means is we have a very exciting type of therapy platform called CAR T therapy where we're basically engineering a patient's own immune system cells and basically designing it so that it's a killer type of cell and that it's only going to kill the cancer cell and not other parts of the human body. And that's really the most exciting part of lymphoma treatment at this time. It's a huge type of research. Twenty-thirty years ago we only had one type of chemotherapy for diffuse large B cell lymphoma called CHOP CHOP and then we developed an antibody drug called Rituximab and fast forward to twenty-twenty-one we have many different types of therapies ranging from oral pills to immunotherapy drugs like I just mentioned CAR T is extremely exciting because patients who've progressed after two or three lines of therapy can be cured up to sixty percent of the time with CAR T therapy. Well when I treat a patient I think the first thing that has to be focused on is the biology of the cancer which is really the best way that we know how to treat lymphoma is if we have a target we're going to go after it and that's what we know with the CAR T treatments with CD-19 which is basically a marker on the lymphoma cell. And after the biology though I really do try to look at the patient as a whole person whether they're 75 but very fit then I will give them something more aggressive or if they're more very very sick and lying in bed all day then I know that something like combination chemotherapy might be too too harmful for them and we have to take that into account what what to do to not harm the patient but to still benefit the patient. So here at John Thur we have a new outcomes in Valley Care Research Division it was formed when I joined the cancer center in 2019 and the whole goal of this division is to really understand based off of all different variables whether it's their electronic health chart or a survey they fill out for us but understand what's the best outcome we can get for the patient with all the information that's available to us.